271 results
Page 5 of 14
S-8
EX-4.8
fdtln16 5oj
12 Aug 21
Registration of securities for employees
4:50pm
8-K
EX-99.1
1a1c2ur xi1jfr5pva7
18 Mar 21
Regulation FD Disclosure
4:14pm
8-K
EX-99.1
2mp7tweelmszc73pl
17 Mar 21
Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update
4:36pm
8-K
EX-1.1
ojl he50c
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
424B5
1ptrezjd bhnr
17 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
70wu8
16 Feb 21
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
8:10am
424B5
0dv1y9 4tbqx6ulpp
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
nhdoqumbl8iuab8abdb
12 Nov 20
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
4:57pm
8-K
x5e580z1j
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
8-K
EX-10.1
kjjrr
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm